Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors (LDTam)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01196936
Recruitment Status : Active, not recruiting
First Posted : September 9, 2010
Last Update Posted : December 8, 2017
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
University Health Network, Toronto
University of Michigan
Dana-Farber Cancer Institute
Mayo Clinic
University of Washington
City of Hope National Medical Center
M.D. Anderson Cancer Center
University of Chicago
University of Minnesota - Clinical and Translational Science Institute
University of Colorado, Denver
Wake Forest University
Information provided by (Responsible Party):
Smitia Bhatia, University of Alabama at Birmingham

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : November 2018
  Estimated Study Completion Date : November 2019